The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET ...
The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET gene fusions and encouraging clinical trial outcomes. With the approval ...